09/29/2025 3:38 PM | Bicara Therapeutics (Subject) Meisner Lara (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2025 4:01 PM | Bicara Therapeutics (Issuer) Meisner Lara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2025 6:41 AM | Bicara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/31/2025 1:56 PM | Bicara Therapeutics (Subject) Invus Global Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
07/17/2025 10:08 AM | Bicara Therapeutics (Subject) FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
07/17/2025 10:11 AM | Bicara Therapeutics (Subject) FMR LLC (Filed by)
| Form SCHEDULE 13G | |
06/18/2025 4:12 PM | Bicara Therapeutics (Issuer) Meisner Lara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2025 3:33 PM | Bicara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2025 3:34 PM | Bicara Therapeutics (Issuer) RA Capital Nexus Fund III, L.P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2025 3:37 PM | Bicara Therapeutics (Issuer) Haviland Kate (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2025 3:26 PM | Bicara Therapeutics (Issuer) Bowden Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2025 3:27 PM | Bicara Therapeutics (Issuer) Simson Jake (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2025 3:28 PM | Bicara Therapeutics (Issuer) Robertson Scott M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/13/2025 6:43 AM | Bicara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2025 8:12 AM | Bicara Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2025 6:45 AM | Bicara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2025 5:35 PM | Bicara Therapeutics (Issuer) Meisner Lara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2025 3:21 PM | Bicara Therapeutics (Subject) Meisner Lara (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025 8:14 AM | Bicara Therapeutics (Subject) FMR LLC (Filed by)
| Form SCHEDULE 13G | |
01/13/2025 7:02 AM | Bicara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |